FDA NDC
Xultophy 100/3.6
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 0169-2911
- Proprietary name
- Xultophy 100/3.6
- Nonproprietary name
- insulin degludec and liraglutide
- Labeler
- Novo Nordisk
- Dosage form
- INJECTION, SOLUTION
- Strength
- 100 [iU]/mL
Run it in Rivvi
Which 2027 plans near you dropped or restricted insulin degludec and liraglutide?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.